Pfizer‐BioNTech SARS‐CoV‐2 mRNA vaccine‐associated erythema multiforme

Luca Borg(Mater Dei Hospital), L. Scerri(Mater Dei Hospital), Dillon Mintoff(University of Malta), Alexandra Betts(Mater Dei Hospital), David Pisani(Mater Dei Hospital), Liam Mercieca(Mater Dei Hospital), Daniel Micallef(Mater Dei Hospital)
Journal of the European Academy of Dermatology and Venereology
September 21, 2021
10.1111/jdv.17682
Cited by 24

Related Papers

The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Psoriasis: Keratinocytes or Immune Cells – Which Is the Trigger?
|Dermatology|2018|227
Psoriasis and Microbiota: A Systematic Review
|Diseases|2018|135
The Genomic Architecture of Hidradenitis Suppurativa—A Systematic Review
|Frontiers in Genetics|2022|117
EULAR study group on ‘MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders
|Annals of the Rheumatic Diseases|2023|79